$SSKN
STRATA Skin Sciences, Inc.

2013 Q4 Form 10-Q Financial Statement

#000119312513435086 Filed on November 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $140.0K $107.7K $69.13K
YoY Change 16.67% 55.81%
Cost Of Revenue -$100.0K $1.977M $568.9K
YoY Change -110.31% 247.43%
Gross Profit $240.0K -$1.869M -$499.8K
YoY Change -128.24% 273.93%
Gross Profit Margin 171.43% -1735.07% -722.98%
Selling, General & Admin $3.100M $3.481M $3.470M
YoY Change -21.52% 0.31% -5.96%
% of Gross Profit 1291.67%
Research & Development $540.0K $856.8K $1.399M
YoY Change -58.14% -38.74% -42.68%
% of Gross Profit 225.0%
Depreciation & Amortization $650.0K $681.8K $250.0K
YoY Change 66.67% 172.7% 78.57%
% of Gross Profit 270.83%
Operating Expenses $3.640M $4.337M $1.399M
YoY Change -30.53% 210.15% -77.19%
Operating Profit -$3.400M -$6.206M -$5.368M
YoY Change -44.17% 15.62% -12.44%
Interest Expense -$210.0K $222.8K $10.00K
YoY Change 2127.58% 0.0%
% of Operating Profit
Other Income/Expense, Net $10.00K -$1.198M $4.954K
YoY Change 0.0% -24286.11% -50.46%
Pretax Income -$4.610M -$7.400M -$5.360M
YoY Change -24.18% 38.06% -12.27%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.610M -$7.404M -$5.357M
YoY Change -24.18% 38.22% -12.33%
Net Earnings / Revenue -3292.86% -6874.6% -7749.33%
Basic Earnings Per Share -$1.72
Diluted Earnings Per Share -$5.011M -$1.72 -$8.787M
COMMON SHARES
Basic Shares Outstanding 47.37M shares 4.312M shares
Diluted Shares Outstanding 4.312M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.780M $2.620M $13.28M
YoY Change -51.91% -80.27% -21.88%
Cash & Equivalents $3.783M $2.620M $13.28M
Short-Term Investments
Other Short-Term Assets $880.0K $670.0K $620.0K
YoY Change -9.28% 8.06% -27.91%
Inventory $5.631M $271.6K $660.0K
Prepaid Expenses
Receivables $57.00K $50.92K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $10.35M $3.608M $14.65M
YoY Change 6.9% -75.37% -17.97%
LONG-TERM ASSETS
Property, Plant & Equipment $3.691M $9.418M $5.240M
YoY Change -49.78% 79.74% 202.89%
Goodwill
YoY Change
Intangibles $42.00K $43.06K
YoY Change -10.64%
Long-Term Investments
YoY Change
Other Assets $48.00K $80.13K $190.0K
YoY Change -42.86% -57.83% -70.77%
Total Long-Term Assets $3.781M $9.542M $5.490M
YoY Change -50.16% 73.8% 125.0%
TOTAL ASSETS
Total Short-Term Assets $10.35M $3.608M $14.65M
Total Long-Term Assets $3.781M $9.542M $5.490M
Total Assets $14.13M $13.15M $20.14M
YoY Change -18.17% -34.71% -0.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.479M $1.425M $1.280M
YoY Change -20.05% 11.31% 103.17%
Accrued Expenses $844.0K $878.5K $910.0K
YoY Change -11.72% -3.46% 37.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.652M $2.629M $2.360M
YoY Change 87.21% 11.38% 78.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $180.0K $230.0K $210.0K
YoY Change -35.71% 9.52% 61.54%
Total Long-Term Liabilities $184.0K $231.3K $210.0K
YoY Change -33.33% 10.15% 61.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.652M $2.629M $2.360M
Total Long-Term Liabilities $184.0K $231.3K $210.0K
Total Liabilities $5.836M $2.860M $2.570M
YoY Change 77.12% 11.28% 77.24%
SHAREHOLDERS EQUITY
Retained Earnings -$168.1M -$163.5M
YoY Change 18.25%
Common Stock $176.4M $173.8M
YoY Change 12.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.296M $10.29M $17.57M
YoY Change
Total Liabilities & Shareholders Equity $14.13M $13.15M $20.14M
YoY Change -18.17% -34.71% -0.79%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$4.610M -$7.404M -$5.357M
YoY Change -24.18% 38.22% -12.33%
Depreciation, Depletion And Amortization $650.0K $681.8K $250.0K
YoY Change 66.67% 172.7% 78.57%
Cash From Operating Activities -$3.900M -$5.000M -$4.960M
YoY Change -22.47% 0.81% 26.85%
INVESTING ACTIVITIES
Capital Expenditures -$320.0K -$1.100M -$2.280M
YoY Change -87.15% -51.75% 7500.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$320.0K -$1.100M -$2.280M
YoY Change -87.15% -51.75% 7500.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.380M -6.420M 3.300M
YoY Change 153.77% -294.55%
NET CHANGE
Cash From Operating Activities -3.900M -5.000M -4.960M
Cash From Investing Activities -320.0K -1.100M -2.280M
Cash From Financing Activities 5.380M -6.420M 3.300M
Net Change In Cash 1.160M -12.52M -3.940M
YoY Change -121.48% 217.77% 0.0%
FREE CASH FLOW
Cash From Operating Activities -$3.900M -$5.000M -$4.960M
Capital Expenditures -$320.0K -$1.100M -$2.280M
Free Cash Flow -$3.580M -$3.900M -$2.680M
YoY Change 40.94% 45.52% -30.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27996871
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32204720 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32204720 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Loans Payable Current
LoansPayableCurrent
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
956541
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1850102
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3019180
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
13975210
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
156142873
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142199868
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
171726
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
143772
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
32205
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17269813
CY2012Q4 us-gaap Liabilities
Liabilities
3294603
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
275423
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
40811
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
131651
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Assets Current
AssetsCurrent
9682706
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
47308
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
84127
CY2012Q4 us-gaap Assets
Assets
17269813
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7861524
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
179956
CY2012Q4 us-gaap Inventory Net
InventoryNet
675602
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
106141
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
965624
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7349531
CY2013Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5300000
CY2013Q1 mela Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
563000
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75000 shares
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
750000 shares
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47372890 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13275849
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43139027 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43139027 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
126033
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q3 us-gaap Loans Payable Current
LoansPayableCurrent
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
878503
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1424795
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2628577
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
10289565
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
173784092
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-163537666
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
267451
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
43139
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13149465
CY2013Q3 us-gaap Liabilities
Liabilities
2859900
CY2013Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
231323
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
57828
CY2013Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
105290
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Assets Current
AssetsCurrent
3607890
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43064
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
80127
CY2013Q3 us-gaap Assets
Assets
13149465
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2620291
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50915
CY2013Q3 us-gaap Inventory Net
InventoryNet
271588
CY2013Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
727000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
665096
CY2013Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
425000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9418384
CY2013Q3 mela Obsolete Inventory Reserves
ObsoleteInventoryReserves
325000
CY2013Q3 mela Capitalized Costs Incurred
CapitalizedCostsIncurred
11200000
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
900000 shares
CY2013Q2 mela Additional Stock Based Compensation
AdditionalStockBasedCompensation
423000
dei Trading Symbol
TradingSymbol
MELA
dei Entity Registrant Name
EntityRegistrantName
MELA SCIENCES, INC. /NY
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001051514
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.77 pure
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41828144 shares
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0084 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15513449
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3449295 shares
us-gaap Revenues
Revenues
396206
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-300528
us-gaap Gross Profit
GrossProfit
-4042005
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
200000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15400
us-gaap Repayments Of Debt
RepaymentsOfDebt
6425000
us-gaap Investment Income Interest
InvestmentIncomeInterest
7323
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-983330
us-gaap Operating Income Loss
OperatingIncomeLoss
-19724189
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-76944
us-gaap Net Income Loss
NetIncomeLoss
-21337798
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-79014
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4865358
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-503345
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1010712
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
99283
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-17739
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12440457
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15137574
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
69364
us-gaap Share Based Compensation
ShareBasedCompensation
1157471
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
52097
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1790037
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5241233
us-gaap Interest Expense
InterestExpense
563143
mela Write Off Of Unamortized Loan Costs
WriteOffOfUnamortizedLoanCosts
983330
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30438669 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14185036
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2459506 shares
us-gaap Revenues
Revenues
156134
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-351782
us-gaap Gross Profit
GrossProfit
-915223
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14950
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15789873
us-gaap Cost Of Revenue
CostOfRevenue
4438211
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4865358
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3241727
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
17017
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18059
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
86042
mela Proceeds From Borrowings And Warrant Exercises
ProceedsFromBorrowingsAndWarrantExercises
6000000
mela Payments For Borrowings And Warrant Exercises
PaymentsForBorrowingsAndWarrantExercises
245358
mela Expiration Period Of Option Vested
ExpirationPeriodOfOptionVested
September 2013
mela Fair Value Assumptions Change In Unobservable Inputs
FairValueAssumptionsChangeInUnobservableInputs
0.10 pure
mela Provision For Inventory Reserve
ProvisionForInventoryReserve
325000
mela Write Off Of Unamortized Financing Costs
WriteOffOfUnamortizedFinancingCosts
41166
mela Recognized Stock Based Compensation
RecognizedStockBasedCompensation
265000
mela Warrant Liability Increase Decrease
WarrantLiabilityIncreaseDecrease
89859
mela Noncash Interest Expense
NoncashInterestExpense
163569
mela Amount Reclassified From Warrant Liability To Equity
AmountReclassifiedFromWarrantLiabilityToEquity
652442
mela Capitalized Amount Related To System Cost
CapitalizedAmountRelatedToSystemCost
4900000
us-gaap Investment Income Interest
InvestmentIncomeInterest
28280
CY2013Q2 mela Common Stock Exercise Price
CommonStockExercisePrice
0.73
CY2013Q2 mela Number Of Consultants
NumberOfConsultants
2 Consultant
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7501
us-gaap Operating Income Loss
OperatingIncomeLoss
-16637320
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
100578
us-gaap Net Income Loss
NetIncomeLoss
-16594090
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
566287
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3668410
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
773946
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
4167
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10215501
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3132424
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
150876
us-gaap Share Based Compensation
ShareBasedCompensation
1106296
us-gaap Depreciation And Amortization
DepreciationAndAmortization
583058
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14721022
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3093839
us-gaap Cost Of Revenue
CostOfRevenue
1071357
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3668410
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5506596
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
50904
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
38585
mela Write Off Of Unamortized Financing Costs
WriteOffOfUnamortizedFinancingCosts
62391
mela Reclassification From Other Assets To Property And Equipment
ReclassificationFromOtherAssetsToPropertyAndEquipment
522014
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6100000 shares
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7300000
CY2013Q1 mela Price Of Public Offering
PriceOfPublicOffering
1.30
CY2013Q1 mela Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
7900000
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
900000 shares
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
1.24
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
3.75
CY2013Q2 mela Option Vested To Chief Executive Officer
OptionVestedToChiefExecutiveOfficer
1200000 shares
CY2013Q2 mela Share Based Compensation Arrangement By Share Based Payment Award Options Period Of Exercise Vested Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPeriodOfExerciseVestedOption
P90D
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
200000 shares
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
96000
CY2013Q2 mela Share Based Compensation Arrangements By Share Based Payment Award Options Vesting Period
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestingPeriod
Quarterly over one year
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
200000
CY2013Q2 mela Recognized Stock Based Compensation
RecognizedStockBasedCompensation
80000
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30667371 shares
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2012Q3 us-gaap Revenues
Revenues
69127
CY2012Q3 us-gaap Gross Profit
GrossProfit
-499772
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4954
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
5875
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2013Q3 us-gaap Revenues
Revenues
107707
CY2013Q3 us-gaap Gross Profit
GrossProfit
-1868794
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
916000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5400
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5367707
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5356878
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3469435
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
568899
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1398500
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43121179 shares
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2508
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6206247
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-7404427
CY2013Q3 us-gaap Defined Benefit Plan Special Termination Benefits
DefinedBenefitPlanSpecialTerminationBenefits
100000
CY2013Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1010712
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3480689
CY2013Q3 us-gaap Interest Expense
InterestExpense
222758
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
1976501
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
856764
CY2013Q3 mela Recognized Stock Based Compensation
RecognizedStockBasedCompensation
265000
CY2013Q3 mela Write Off Of Unamortized Loan Costs
WriteOffOfUnamortizedLoanCosts
983330
CY2013Q3 mela User Agreement Expiration Term
UserAgreementExpirationTerm
P2Y

Files In Submission

Name View Source Status
0001193125-13-435086-index-headers.html Edgar Link pending
0001193125-13-435086-index.html Edgar Link pending
0001193125-13-435086.txt Edgar Link pending
0001193125-13-435086-xbrl.zip Edgar Link pending
d592914d10q.htm Edgar Link pending
d592914dex311.htm Edgar Link pending
d592914dex312.htm Edgar Link pending
d592914dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mela-20130930.xml Edgar Link completed
mela-20130930.xsd Edgar Link pending
mela-20130930_cal.xml Edgar Link unprocessable
mela-20130930_def.xml Edgar Link unprocessable
mela-20130930_lab.xml Edgar Link unprocessable
mela-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending